![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.65 | 4.52 | 4.99 | - | 172,565 | 10:52:51 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/6/2020 11:51 | And to ensure the Director's Salary / Bonus increases. | ![]() gbh2 | |
18/6/2020 11:37 | Well they raised £14m early this year for the purposeThe net proceeds of the Fundraising will be used: (i) to fund the COVID-19 clinical trial activity; (ii) the manufacture of the SNG001 drug product and other supply chain considerations; and (iii) for general working capital requirements and to strengthen the Company's balance sheet. | ![]() kooba | |
18/6/2020 10:39 | Good update but the extended home trial is gonna need paying for .... not sure where that's coming from !! | ![]() paradise city |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions